Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy.

Pharmacoeconomics · 2023 · PMC9883339 · PMID 36662417

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

WTP variations in the range 0–100,000€ showed an increasing trend for the NMB corresponding to the increase in the WTP for all treatment lines with similar trends for 4L and 5L (Fig. 7 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.